FDA Qualifies Health Claim About Early Peanut Introduction — Physician’s First Watch

Medical News |
September 8, 2017

FDA Qualifies Health Claim About Early Peanut Introduction

By Amy Orciari Herman

Edited by André Sofair, MD, MPH

The FDA is qualifying a health claim surrounding early introduction of peanut-containing foods to high-risk infants.

In January, new guidelines from the National Institute of Allergy and Infectious Diseases advised that infants with severe eczema, egg allergy, or both should have peanut-containing foods introduced as early as age 4 to 6 months, following allergy testing. Early introduction, the group said, could help lower the risk for peanut allergy later in childhood.

Now, the FDA says the following claim is more appropriate: "For most infants with severe eczema and/or egg allergy who are already eating solid foods, introducing foods containing ground peanuts between 4 and 10 months of age and continuing consumption may reduce the risk of developing peanut allergy by 5 years of age." This claim will soon be found on the labels of some age-appropriate foods containing ground peanuts.

The agency emphasizes that whole peanuts are a choking hazard for young children, and that parents should check with their child's clinician before introducing peanut-containing foods.

Your Comment

(will not be published)

Filtered HTML

  • Allowed HTML tags: <a> <em> <strong> <cite> <blockquote> <code> <ul> <ol> <li> <dl> <dt> <dd>
  • Web page addresses and e-mail addresses turn into links automatically.
  • Lines and paragraphs break automatically.

Plain text

  • No HTML tags allowed.
  • Web page addresses and e-mail addresses turn into links automatically.
  • Lines and paragraphs break automatically.
Do you have any conflict of interest to disclose?
CAPTCHA
This question is for testing whether you are a human visitor and to prevent automated spam submissions.

Vertical Tabs

* Required

Reader comments are intended to encourage lively discussion of clinical topics with your peers in the medical community. We ask that you keep your remarks to a reasonable length, and we reserve the right to withhold publication of remarks that do not meet this standard.

PRIVACY: We will not use your email address, submitted for a comment, for any other purpose nor sell, rent, or share your e-mail address with any third parties. Please see our Privacy Policy.